CHRNA5/CHRNA3 Locus Associates with Increased Mortality among Smokers. (3rd July 2016)

• Record Type: Journal Article
• Authors: Kupiainen, Henna; Kuokkanen, Mikko; Kontto, Jukka; Virtamo, Jarmo; Salomaa, Veikko; Lindqvist, Ari; Kilpeläinen, Maritta; Laitinen, Tarja
• Is Part Of: COPD. Volume 13:Number 4(2016)
• Page Start: 464
• Page End: 470
• Publication Date: 2016-07-03
• Subjects: COPD -- mortality -- single nucleotide polymorphism -- smoking; Lungs -- Diseases, Obstructive -- Periodicals; 616.24
• DOI: 10.3109/15412555.2015.1049260
• Languages: English
• ISSNs: 1541-2555

Abstract

Abstract: Polymorphisms in the nicotinic acetylcholine receptor gene ( CHRNA5/CHRNA3 locus) have been associated with several smoking related traits such as nicotine dependence, cigarette consumption, smoking cessation, lung cancer, and COPD. The aim of this candidate gene study was to study the locus among the Finnish COPD patients and long-term smokers with regard to COPD risk, smoking behavior, cancer, and all-cause mortality. Genotyping of rs1051730, the locus tagging SNP was done in two longitudinal cohorts: Finnish COPD patients (N = 575, 74% men) and long-term smokers, all men (N = 1911). Finnish population sample (N = 1730) was used as controls. The analyses were done using logistic and Cox regression. The main findings were that the minor allele increased the risk of COPD when compared to the Finnish population at large (OR = 1.4, 95% CI 1.2-1.7, p = 3.2 × 10-5). Homozygosity for the risk allele was associated in both cohorts with all-cause mortality (crude HR 2.2, 95% CI 1.2–3.8 and 1.3, 95% CI 1.1–1.5, respectively), with any type of cancer (crude OR 2.3, 95% CI 1.0–5.1) among the COPD patients and with the number of pack-years (crude OR 1.4, 95% CI 1.1–1.9) among the male smokers. CHRNA5/CHRNA3 locus tagged by rs1051730, which has been previously associated with several smoking related diseases was now shown to be associated also with increased all-cause mortality among long-term smokers with or without clinical COPD further emphasizing the clinical importance of the finding.